Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Journals Home

SIGN IN

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Narrow View

NARROW

Content Type

Meeting Abstract (12)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (13)

Article Type

ARVO Annual Meeting Abstract (12)
Retina (1)

Topics

Eye Anatomy and Disorders (1)
Immunology and Microbiology (1)
Pharmacology (1)
Retina (1)

Tags

edema (1)
intravitreal injections (1)
mice (1)
plasma kallikrein (1)
retina (1)
vascular endothelial growth factor a (1)

Specify Date Range

From: To: Apply

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Novel oral plasma kallikrein (PKa) inhibitors KV998052 and KV998054 ameliorate VEGF-induced retinal thickening in a murine model of retinal edema

Nivetha Murugesan; Allen C Clermont; Stephen J Pethen; Lily Li; Edward J Duckworth; Sally L Hampton; Edward Feener

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2596. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Complement C3 mediates vascular endothelial growth factor (VEGF) induced retinal edema but not visual dysfunction in mice.

Allen C Clermont; Alex Feener; Nivetha Murugesan; Lloyd P Aiello; Edward Feener

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2791. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Vascular endothelial growth factor (VEGF) mediates electroretinogram (ERG) dysfunction in mice through plasma kallikrein and nitric oxide

Allen C Clermont; Fabricio Simao; Nivetha Murugesan; Paul Huang; Lloyd P Aiello; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3463. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

A novel oral plasma kallikrein (PKal) inhibitor KV123833 blocks VEGF-mediated retinal vascular hyperpermeability in a murine model of retinal edema

Nivetha Murugesan; Allen C Clermont; Louise J Rushbrooke; Peter A Robson; Robrecht Thoonen; Stephen J Pethen; Sally L Hampton; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3464. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Effects of Vascular endothelial growth factor (VEGF) on electroretinogram (ERG) amplitude in rats are mediated by bradykinin.

Allen C Clermont; Nivetha Murugesan; Tuna Ustunkaya; Brianna Mastromarino; Lloyd P Aiello; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5347. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Increased FXII activity in vitreous of patients with Diabetic Macular Edema (DME) and in animal models of VEGF- and bradykinin-induced retinal edema

Tuna Ustunkaya; Nivetha Murugesan; Allen C Clermont; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4183. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Title: Complement component 3 (C3) is increased in vitreous in diabetic macular edema and is required for bradykinin (BK)-induced retinal edema.

Nivetha Murugesan; Allen C Clermont; Takeshi Kita; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Vascular endothelial growth factor (VEGF) and bradykinin induce increased electroretinogram amplitude and decreased visual acuity.

Allen C Clermont; Nivetha Murugesan; Cheng-mao Lin; Sarah R Sheskey; David A Antonetti; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

Retina May 2016

Plasma Kallikrein Mediates Vascular Endothelial Growth Factor–Induced Retinal Dysfunction and Thickening

PDF

Allen Clermont; Nivetha Murugesan; Qunfang Zhou; Takeshi Kita; Peter A. Robson; Louise J. Rushbrooke; D. Michael Evans; Lloyd Paul Aiello; Edward P. Feener
TAGS: vascular endothelial growth factor a, edema, plasma kallikrein, mice, retina, intravitreal injections
Invest. Ophthalmol. Vis. Sci.. 2016; 57(6):2390-2399. doi: https://doi.org/10.1167/iovs.15-18272

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Proteomic characterization of retinal edema in rats

Nivetha Murugesan; Allen C Clermont; LeiLei Sun; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4693. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Vascular endothelial growth factor (VEGF)- and the kallikrein kinin system (KKS)- induced neuronal dysfunction in a rodent model of retinal edema.

Allen C Clermont; Nivetha Murugesan; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5487. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2014

Plasma kallikrein (PKal) deficiency ameliorates the effects of vascular endothelial growth factor (VEGF) on retinal hyperpermeability and edema.

Allen C Clermont; Qunfang Zhou; Nivetha Murugesan; Ward Fickweiler; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):594. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2014

Role of Akt in VEGF-, bradykinin-, and diabetes-induced retinal dysfunction and edema

Ward Fickweiler; Allen C Clermont; Nivetha Murugesan; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2256. doi: https://doi.org/

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept